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Crippled clock hinders healing
Diabetic eye damage may start in bone marrow, suggest Busik and colleagues. Damaged bone 
marrow nerves and disrupted circadian genes hampered the release of progenitor cells that are 
required to repair diabetes-induced vessel injury in the eye.
Up to 45% of diabetic adults in the US develop retinopathy, a potentially blinding condition. 
Although high glucose levels and oxidative stress may cause the initial eye injury, Busik et al. 
suggest that the inability to repair damage causes the real problem. Normally, endothelial 
progenitor cells (EPCs) exiting the bone marrow help to regenerate damaged vessels during sleep. 
This nocturnal EPC egress is faulty in patients with diabetes, creating abnormally low levels of 
nighttime EPCs. Here, the authors show that diabetic rats have similar EPC deficits during the 
day when they normally sleep.
Diabetic rats showed signs of damage to bone marrow nerves, which trigger the signals 
required for EPC exit. Nerve damage coincided with a drop in the expression of circadian “clock” 
genes that control the ebb and flow of EPC migration. With fewer reparative EPCs on the move, 
damaged eye vessels accumulated in diabetic animals. Circadian rhythm disruption has also been 
blamed for the glucose and blood pressure complications characteristic of diabetes.
Because nerve damage and clock gene irregularities preceded eye disease, the authors suggest 
that the resulting EPC malfunction leads to retinopathy. What triggers nerve damage and 
circadian disruption is not yet known. Senior author Maria Grant suspects a role for nitric 
oxide, a known regulator of circadian gene transcription that is commonly elevated in patients 
with diabetes.
XP mutant power!
Patients with the DNA-repair disorder xeroderma pigmentosum (XP) suffer from a wide range 
of symptoms; some are mild, such as excessive freckling after sun exposure, whereas others are 
more severe, including skin cancer and neurodegeneration. Genetic variation underlies this 
heterogeneity, argue Ueda and colleagues.
The so-called “causative” XP mutation (R683W) lies within the transcription complex TFIIH, 
which helps to transcribe nearly all genes and to repair damaged DNA. The complex includes 
three subunits with separate enzymatic functions. The R683W mutation is in the XPD subunit 
and disrupts helicase activity.
XP patients can be homozygous or heterozygous for the R683W mutation. And some 
heterozygotes bear secondary mutations on the opposing XPD allele. Contrary to popular 
belief, Ueda et al. suggest that these additional mutations matter. Patients with different 
secondary mutations had different XP symptoms. And their secondary mutations had a variety 
of molecular outcomes, ranging from the deletion of an amino acid to the production of a 
truncated protein.
The authors found that different allelic combinations interfered with TFIIH’s repair and 
transcription cascades in unique ways. Some combinations hampered DNA repair by weakening 
a link between XPD and another subunit of TFIIH, which decreased XPD’s helicase activity. 
Other mutations indirectly disturbed the function of kinase required for the phosphorylation and 
activation of RNA polymerase II.
Ueda and colleagues thus suggest that secondary XPD mutations can either enhance or 
counteract clinical symptoms. Exactly how the nuances in XPD function dictate specific symptoms 
is not yet clear, and many more XPD mutations remain to be investigated.
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Regulating the regulators
An inhibitory receptor–ligand pair does more than stifle immune responses—it helps the cells that 
stifle immune responses, report Francisco and colleagues.
Regulatory T (T reg) cells halt aggressive immune responses before they cause damage. But 
too many T reg cells can obstruct a needed response against cancer or infection. Now, Francisco 
et al. reveal that the inhibitory programmed death (PD) 1 pathway, known to induce tolerance, 
promotes T reg cell activity by stimulating and maintaining the expression of Foxp3, the signature 
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Inflammation stops at Bop
Bordetella, the pathogen underlying whooping cough, short-circuits the host immune response by 
triggering the antiinflammatory cytokine IL-10. Now, Nagamatsu and colleagues nab the bacterial 
protein that does the job.
Bacteria often thwart inflammatory responses by injecting effector proteins into host cells 
through a syringe-like organelle called the type III secretion system (T3SS). These effector 
proteins manipulate the host immune response in a variety of ways. Here, Nagamatsu et al. discover 
the first bacterial effector protein known to trigger IL-10.
Bordetella secretes at least two T3SS effector proteins into host cells, BopC and BopN. BopC 
induces cell death, and BopN is now shown to trigger IL-10 when it moves into the nucleus of 
dendritic cells and macrophages. BopN inhibited MAP kinase signaling and activated the transcription 
factor SP-1, which is known to promote IL-10 production. BopN also induced NF-B p50 
translocation at the expense of p65, a situation that may also promote IL-10 production.
Mice infected with a BopN-deficient strain of Bordetella produced less IL-10, effectively 
recruited neutrophils to the site of infection, and rid themselves of the bug. Mice lacking IL-10 
cleared infection whether or not BopN was intact. And exposing mice to the BopN-deficient 
strain protected them against later challenge with wild-type bacteria, perhaps by ramping up the 
production of the inflammatory cytokine IFN-.
Because MAP kinase and NF-B signaling control the expression of thousands of genes, 
BopN might alter other cytokines as well. A prior study showed that an unidentified Bordetella 
T3SS protein shuts down IFN- production. Whether this was a result of IL-10 suppressing IFN-–
producing cells, of BopN altering NF-B activation, or the action of a different effector protein 
altogether remains to be seen.
Co-culture of PD-L1–expressing 
beads (red) and naive T cells (purple) 
promotes their conversion into T reg 
cells (green).
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clearance of infection.
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In mice lacking PD-ligand (PD-L) 1 and PD-L2, transferred T cells failed to convert into T reg 
cells, and the mice quickly succumbed to inflammatory disease. Factors like TGF-, IL-2, and 
Runx3 also help trigger and maintain T reg cells. PD-L1 augmented TGF- signals, but also 
stimulated Foxp3 on its own. The authors also show that PD-L1 biased the differentiation of 
naive T cells toward a T reg cell fate by obstructing the Akt-mTOR signaling pathway required 
for effector T cell survival.
The PD-1 pathway keeps inflammation in check, the authors say. Inflammatory cytokines 
drive PD-1 expression, which in turn triggers T reg cells that dampen the inflammation. 
Manipulating this balance has been a long-standing therapeutic goal. Indeed, PD-1 and PD-L1 
inhibitors are in clinical trials as anticancer agents. Francisco et al. suggest that PD-1 and PD-L1 
agonists could also be used for the opposite effect—to sustain T reg cell function during organ 
transplantation or autoimmunity.
Poking through lymphatic portals
Dendritic cells (DCs) creep like amoebas into lymph vessels. Pflicke and Sixt catch them squeezing 
through minute pores and trap doors to enter.
Two barriers surround vessels—the endothelium and the basement membrane. Leukocytes 
use integrins and proteases to adhere to and drill through blood vessel walls as they exit. Entrance 
into lymph vessels, however, is mysteriously different because it requires neither tool. To figure 
out how leukocytes barge in, Pflicke and Sixt used live cell imaging to follow DC migration in 
explanted skin from mouse ears.
A close look at the lymphatic basement membrane revealed periodic perforations. DCs 
squeezed through these holes by inserting projections and then swelling until the gaps widened 
enough for the cell bodies to slip through. At the next barrier, the lymphatic endothelium, the 
cells took advantage of flexible oak leaf–shaped junctions, which are known to flap open in only 
one direction, allowing the cells in but not out.
This manner of DC lymphatic travel may not apply outside of the afferent lymphatic system 
because not all linings bear pores or hinge-like junctions. Entering and exiting blood vessels, for 
example, might be more restricted because blood vessels must be tightly sealed against fluid leaks. 
Nonetheless, lymphatic migration is far from free-form. Visualizing the chemokine gradients that 
likely steer DCs into and around lymphatic vessels is the team’s next challenge.
Dendritic cells (red) enter lymphatic 
vessels (green) through perforations 
in the basement membrane.